These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28283393)

  • 1. Effect of metformin on exercise capacity in metabolic syndrome.
    Paul AA; Dkhar SA; Kamalanathan S; Thabah MM; George M; Chandrasekaran I; Gunaseelan V; Selvarajan S
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S403-S406. PubMed ID: 28283393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine.
    Chen CH; Chiu CC; Huang MC; Wu TH; Liu HC; Lu ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):925-31. PubMed ID: 18082302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
    Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
    J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries for patients. The effect of diet and exercise or metformin on the metabolic syndrome.
    Ann Intern Med; 2005 Apr; 142(8):I46. PubMed ID: 15838061
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of metformin on insulin resistance and exercise parameters in patients with heart failure.
    Wong AK; Symon R; AlZadjali MA; Ang DS; Ogston S; Choy A; Petrie JR; Struthers AD; Lang CC
    Eur J Heart Fail; 2012 Nov; 14(11):1303-10. PubMed ID: 22740509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS; Kazemi F; Najafian A; Mohammady M; Aminorroaya A; Amini M
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
    Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
    Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.
    Oner G; Muderris II
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):127-31. PubMed ID: 21831508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome.
    Palomba S; Falbo A; Russo T; Manguso F; Tolino A; Zullo F; De Feo P; Orio F
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3128-35. PubMed ID: 17519312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome.
    Paleari L; Burhenne J; Weiss J; Foersch S; Roth W; Parodi A; Gnant M; Bachleitner-Hofmann T; Scherer D; Ulrich CM; Stabuc B; Puntoni M; Coccia G; Petrera M; Haefeli WE; DeCensi A
    Gastroenterology; 2018 Apr; 154(5):1543-1545. PubMed ID: 29526732
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin for Antipsychotic-Related Metabolic Syndrome in Children: Fact or Fiction?
    Naguy A; El-Sori D
    Chin Med J (Engl); 2018 Jun; 131(12):1490-1491. PubMed ID: 29893366
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.
    Li J; Ng EH; Stener-Victorin E; Hu Z; Shao X; Wang H; Li M; Lai M; Xie C; Su N; Yu C; Liu J; Wu T; Ma H
    Trials; 2017 Mar; 18(1):115. PubMed ID: 28274268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of adding exenatide to a regimen of metformin and/or sulfonylurea in type 2 diabetes: an uncontrolled, open-label trial in Hungary.
    Iványi T; Fövényi J; Faludi P; Han J; Macconell L; Wille S; Kiljanski J
    Clin Ther; 2012 Jun; 34(6):1301-13. PubMed ID: 22608106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of metformin on exercise capacity in active males.
    Johnson ST; Robert C; Bell GJ; Bell RC; Lewanczuk RZ; Boulé NG
    Diabetes Obes Metab; 2008 Sep; 10(9):747-54. PubMed ID: 17970761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes.
    Huang Y; Sun J; Wang X; Tao X; Wang H; Tan W
    J Clin Pharm Ther; 2015 Aug; 40(4):461-5. PubMed ID: 26032654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.